NCRI Cancer Conference abstracts
Abstracts from the NCRI Cancer Conferences
Menu
Skip to content
Home
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
64
abstracts found.
Leukemic stem cell interactions with the microenvironment: Friend or foe?
Year:
2016
Session type:
Oral
Theme:
Other
Dominique Bonnet
1
1
The Francis Crick Institute
Long non-coding RNAs – Messages from the dark matter of the cancer genome
Year:
2016
Session type:
Oral
Theme:
Other
Sven Diederichs
1
1
University of Freiburg and German Cancer Research Center (DKFZ)
Control of cell division by long non-coding RNAs
Year:
2016
Session type:
Oral
Theme:
Other
Duncan Odom
1
1
University of Cambridge
Long non-coding RNAs and the regulation of the immune response
Year:
2016
Session type:
Oral
Theme:
Other
Mark Lindsay
1
1
University of Bath
Cancer prevention at the population level: Standardised packaging
Year:
2016
Session type:
Oral
Theme:
Other
Ann McNeill
1
1
King’s College London and the UK Centre for Tobacco
Minimum unit pricing for alcohol: The most cost-effective cancer prevention strategy of all?
Year:
2016
Session type:
Oral
Theme:
Other
Tim Stockwell
1
1
Centre for Addictions Research of British Columbia, University of Victoria
Image quantification: Do numbers help treatment stratification?
Year:
2016
Session type:
Oral
Theme:
Other
Alan Jackson
1
1
University of Manchester
Therapeutic targeting of childhood medulloblastoma: strategies for blocking recurrence
Year:
2016
Session type:
Oral
Theme:
Other
Sheila Singh
1
1
McMaster University
Integrating stem and progenitor cell contribution to intestinal self renewal
Year:
2016
Session type:
Oral
Theme:
Other
Douglas Winton
1
1
Cancer Research UK Cambridge Institute
In search for the lacking driver genes of neuroblastoma
Year:
2016
Session type:
Oral
Theme:
Other
Rogier Versteeg
1
1
Netherlands Bioinformatics Centre
Cancer prevention at the population level: Policies to prevent and treat obesity
Year:
2016
Session type:
Oral
Theme:
Other
Susan Jebb
1
1
University of Oxford
HPV vaccines – how to get the maximum protection
Year:
2016
Session type:
Oral
Theme:
Other
Margaret Stanley
1
1
University of Cambridge
The management of oropharynx cancer in the HPV era
Year:
2016
Session type:
Oral
Theme:
Other
Terry Jones
1
1
Institute of Translational Medicine, University of Liverpool
Sentinal lymph node biopsy in head and neck cancer: Good ideas need proper trials
Year:
2016
Session type:
Oral
Theme:
Other
Mark McGurk
1
1
King’s College London and Guy’s and St Thomas’ Foundation Trust
Exploiting functional information in imaging for decision making in clinical practice
Year:
2016
Session type:
Oral
Theme:
Other
Christina Messiou
1
1
The Royal Marsden Hospital
Molecular imaging for targeted therapy
Year:
2016
Session type:
Oral
Theme:
Other
Arturo Chiti
1
1
Humanitas University
Plasma DNA for early cancer screening
Year:
2016
Session type:
Oral
Theme:
Other
Yuk Ming Dennis Lo
1
1
The Chinese University of Hong Kong
Prostate cancer screening as national programme: Benefits at less harm and less cost
Year:
2016
Session type:
Oral
Theme:
Other
Harry J. de Koning
1
1
Erasmus Medical Center, Rotterdam
Precision early diagnosis for oesophageal cancer
Year:
2016
Session type:
Oral
Theme:
Other
Rebecca Fitzgerald
1
1
MRC Cancer Cell Unit, University of Cambridge
Genome-epigenome interplay in medulloblastoma
Year:
2016
Session type:
Oral
Theme:
Other
Paul Northcott
1
1
St. Jude Children's Research Hospital
Translocations and catastrophe – chromothriptic disruption of transcription factors in ependymoma
Year:
2016
Session type:
Oral
Theme:
Other
Richard Gilbertson
1
1
Cancer Research UK Cambridge Institute
Deep sequencing of circulating tumour DNA for personalised cancer detection and monitoring
Year:
2016
Session type:
Oral
Theme:
Other
Maximilian Diehn
1
1
Stanford University
The versatility of CTCs as a liquid biopsy: Biomarkers, biology and drug development
Year:
2016
Session type:
Oral
Theme:
Other
Caroline Dive
1
1
Cancer Research UK Manchester Institute
Using circulating tumour DNA to improve the management of metastatic castration-resistant prostate cancer
Year:
2016
Session type:
Oral
Theme:
Other
Gerhardt Attard
1
1
The Institute of Cancer Research
The contribution of genomic instability to malignant growth in Drosophila
Year:
2016
Session type:
Oral
Theme:
Other
Cayetano Gonzalez
1
1
IRB-Barcelona and BIST
Aneuploidy as the large adaptive mutation: Mechanism and theory
Year:
2016
Session type:
Oral
Theme:
Other
Rong Li
1
1
Johns Hopkins University School of Medicine
Rhabdovirus based oncolytic virus vaccines
Year:
2016
Session type:
Oral
Theme:
Other
John Bell
1
1
Ottawa Hospital Research Institute
Systemic delivery of Enadenotucirev, a Group B oncolytic Adenovirus for the treatment of cancer
Year:
2016
Session type:
Oral
Theme:
Other
Kerry Fisher
1
1
University of Oxford
How should we combine oncolytic virotherapy with other agents?
Year:
2016
Session type:
Oral
Theme:
Other
Kevin Harrington
1
1
The Institute of Cancer Research
Targeting the androgen receptor in prostate cancer: A resilient foe
Year:
2016
Session type:
Oral
Theme:
Other
Peter Nelson
1
1
Fred Hutchinson Cancer Research Center
Targeting tumour-infiltrating myeloid cells for prostate cancer therapy
Year:
2016
Session type:
Oral
Theme:
Other
Andrea Alimonti
1
1
Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI)
Molecularly stratified therapeutic strategies for lethal prostate cancer
Year:
2016
Session type:
Oral
Theme:
Other
Johann de Bono
1
1
The Institute of Cancer Research
Drug discovery and development to overcome cancer evolution and drug resistance
Year:
2016
Session type:
Oral
Theme:
Other
Paul Workman
1
1
The Institute of Cancer Research
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer
Year:
2016
Session type:
Oral
Theme:
Other
Nnenna Kanu
1
1
UCL Cancer Institute
Mutational signatures and cancer evolution
Year:
2016
Session type:
Oral
Theme:
Other
Serena Nik-Zainal
1
1
Wellcome Trust Sanger Institute
Loss of primary cilia and tissue hyperplasia associated with centrosome amplification
Year:
2016
Session type:
Oral
Theme:
Other
David Glover
1
1
University of Cambridge
Which pro-survival BCL-2 family member should be targeted for the treatment of which cancer?
Year:
2016
Session type:
Oral
Theme:
Other
Andreas Strasser
1
1
The Walter and Eliza Hall Institute
Identifying human cancers to target with BCL-2 inhibition
Year:
2016
Session type:
Oral
Theme:
Other
Anthony Letai
1
1
Dana-Farber Cancer Institute
Harnessing the complex relationship between mitosis and cell death
Year:
2016
Session type:
Oral
Theme:
Other
Pascal Meier
1
1
The Institute of Cancer Research
Why don’t drug companies provide access to drug for use in combination with RT?
Year:
2016
Session type:
Oral
Theme:
Other
Anthony Chalmers
1
1
Glasgow Centre for Cancer Research
The war on prevention: Bellicose cancer metaphors undermine prevention behaviors
Year:
2016
Session type:
Oral
Theme:
Other
David Hauser
1
1
University of Michigan
‘Searching for the new normal’: Exploring the role of language and metaphor in becoming a cancer survivor
Year:
2016
Session type:
Oral
Theme:
Other
Lynda Appleton
1
1
Clatterbridge Cancer Centre
Enhancing patient-centred care: Assessment and management of patients’ unmet needs
Year:
2016
Session type:
Oral
Theme:
Other
Afaf Girgis
1
1
University of New South Wales
Human tumor virus infection and immune control in vivo
Year:
2016
Session type:
Oral
Theme:
Other
Christian Münz
1
1
University of Zurich
Future prospects for novel therapeutics for EBV-associated diseases
Year:
2016
Session type:
Oral
Theme:
Other
Lawrence Young
1
1
University of Warwick
Advances in the radiotherapy treatment of SCLC
Year:
2016
Session type:
Oral
Theme:
Other
Corinne Faivre-Finn
1
1
University of Manchester
Pre-clinical mouse models of SCLC to identify and test novel therapies
Year:
2016
Session type:
Oral
Theme:
Other
Julien Sage
1
1
Stanford University
Immunotherapy and radiotherapy
Year:
2016
Session type:
Oral
Theme:
Other
Tim Illidge
1
1
Cancer Research UK Manchester Institute
Novel drug/radiotherapy combinations
Year:
2016
Session type:
Oral
Theme:
Other
Philippe Lambin
1
1
MAASTRO clinic/Maastricht University
The war on cancer: Reflections from a conscientious objector
Year:
2016
Session type:
Oral
Theme:
Other
Andrew Graystone
1
1
Media Futures
Page 1 of 2
1
...
»
Last »
